Therapeutic Apheresis: New Indications and Emerging Evidence in 2026
A clinical review of therapeutic apheresis beyond established autoimmune uses—covering neurological, metabolic, and post-infectious indications supported by 2025-2026 evidence.
Infectiology
Emerging EvidenceMicroclots, spike protein persistence, brain fog, and treatment approaches.
A clinical review of therapeutic apheresis beyond established autoimmune uses—covering neurological, metabolic, and post-infectious indications supported by 2025-2026 evidence.
LDN reduces neuroinflammation and immune dysregulation driving long COVID fatigue. Clinical evidence, dosing protocol, and how LDN fits a multimodal recovery plan.
Dr. Julian Douwes explains 5-HTP vs tryptophan for serotonin support — dosing, safety, interactions, and clinical use in Lyme disease and post-COVID patients.
Fat-soluble thiamine that crosses cell membranes conventional B1 cannot. How benfotiamine repairs peripheral nerves, reduces oxidative stress, and supports recovery in Lyme, diabetes, and post-COVID neuropathy.
Comparing lumbrokinase and nattokinase for fibrin clearance, biofilm disruption, post-COVID microclots, and cardiovascular health — with clinical dosing guidance.
A physician's guide to HBOT for Long COVID — covering the mechanisms, clinical trial data, patient selection, session protocols, and realistic outcome expectations.
How mitochondrial dysfunction drives fatigue, brain fog, and chronic illness — plus clinical testing and protocols to restore cellular energy production.
Lumbrokinase is a potent fibrinolytic enzyme with emerging evidence for post-COVID microclots, Lyme biofilms, and chronic inflammation. A physician's clinical overview.
L-glutamine is the intestinal lining's primary fuel source. Explore the clinical evidence for leaky gut, Lyme dysbiosis, post-COVID recovery, and optimal dosing protocols.
POTS and dysautonomia affect millions after infection or long COVID. This functional medicine protocol addresses root causes beyond symptom management.
Dr. Douwes reviews hyperbaric oxygen therapy (HBOT): how it works, what the clinical evidence says for longevity, post-COVID, Lyme, and neurological recovery.
A physician's analysis of ozone therapy evidence across chronic infections, post-COVID, wound healing, and autoimmunity — mechanisms, delivery methods, and realistic expectations.
A physician's comparison of H.E.L.P. Apheresis and INUSpheresis — filtering mechanisms, indications, evidence, cost, and which patients benefit from each approach.
Brain fog treatment options from neuroinflammation workup to neuromodulation. Causes include post-COVID, Lyme, MCAS, and mold. TPS, NAD+, and hyperbaric oxygen covered.
How H.E.L.P. apheresis filters LDL, fibrinogen, CRP, and microclots from your blood. Mechanism, session details, evidence, and clinical experience at Klinik St. Georg.
Evidence-based guide to nattokinase for fibrinolysis and microclots. Mechanism, dosing, post-COVID relevance, combination with serrapeptase, and safety with blood thinners.
How microclots and damaged blood vessel linings drive post-COVID symptoms. Dr. Beate Jaeger's research and clinical implications.
How we treat Long COVID and post-COVID syndrome. Mechanisms, diagnostics, and a multimodal treatment program grounded in clinical experience.
Why COVID-19 causes persistent cognitive dysfunction and what can be done about it. Mechanisms, assessment, and treatment strategies.
How H.E.L.P. apheresis removes microclots and inflammatory mediators in Long COVID patients. Session protocols, evidence from Pretorius research, and clinical experience at Klinik St. Georg.
A clinical guide to Long COVID symptoms and treatment based on 500+ patients. Microclots, spike protein persistence, endothelial dysfunction, and the therapies that produce measurable results.
An evidence-based recovery protocol addressing inflammation, clotting, energy, and immune regulation after COVID-19. By Dr. Julian Douwes.